Zhejiang, China

Yunguang Li

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Novartis Ag, Zhejiang Jiuzhou Pharmaceutical Co., Ltd.. Active years: 2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yunguang Li. Retrieved from https://idiyas.com/inventor/yunguang-li

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


 

Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2017

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Yunguang Li: Innovator in NEP Inhibitor Manufacturing

Introduction

Yunguang Li is a notable inventor based in Zhejiang, China. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of processes for producing intermediates used in the manufacture of NEP inhibitors.

Latest Patents

Yunguang Li holds a patent for a process titled "Process for preparing intermediates useful in the manufacture of NEP inhibitors." This invention relates to a new enantioselective process for producing useful intermediates for the manufacture of NEP inhibitors or prodrugs thereof. Specifically, it focuses on NEP inhibitors that comprise a γ-amino-δ-biphenyl-α-methylalkanoic acid or acid ester backbone. He has 1 patent to his name.

Career Highlights

Throughout his career, Yunguang Li has worked with prominent companies in the pharmaceutical industry. Notably, he has been associated with Novartis AG and Zhejiang Jiuzhou Pharmaceutical Co., Ltd. His work has contributed to advancements in drug development and manufacturing processes.

Collaborations

Yunguang Li has collaborated with several professionals in his field, including Guoliang Zhu and Wenfa Ye. These collaborations have further enhanced his research and development efforts.

Conclusion

Yunguang Li's innovative work in the field of NEP inhibitors showcases his expertise and dedication to advancing pharmaceutical chemistry. His contributions are significant in the ongoing development of effective therapeutic agents.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…